FSDCC to Issue Notice to Himachal Pharma Firm Over Ineffective Antibiotic Batch
The Food Safety and Drug Control Commissionerate (FSDCC) is set to issue a formal notice to VADSP Pharmaceutical, located in Baddi, Himachal Pradesh, following the discovery that a batch of the antibiotic Qcepod 200 supplied to Jaipur-based Iqumed Healthcare contains no trace of cephalosporin, the active ingredient essential for its effectiveness as a third-generation antibiotic.
Investigation into Supply Chain and Production Records
A senior FSDCC official has confirmed that the company will be directed to submit complete production and supply records, including bills and related documents. This action is part of the FSDCC's broader effort to establish the supply chain link between the seized medicine in Rajasthan and the manufacturer, ensuring accountability and transparency in the pharmaceutical distribution network.
Ongoing Investigation and Potential Legal Action
The official stated that an investigation at the manufacturer's end is currently underway. After a thorough inquiry, if VADSP Pharmaceutical is found guilty of supplying substandard or ineffective medication, the FSDCC will proceed to file a court case against the company. This move underscores the regulatory body's commitment to safeguarding public health by enforcing strict compliance with drug safety standards.
The incident highlights critical concerns in drug quality control and the importance of rigorous monitoring in the pharmaceutical industry to prevent such lapses that could compromise patient health and treatment outcomes.
